What if dialysis was mobile and automated? What if you’ll install a shunt without the prospect of rejection or infection? What if we only needed patient tissue cells to acquire a replacement, viable kidney? Aside from proven alternatives to kidney care like citrate for kidney stones, longer-term kidney care holds these possibilities and more because of research in a vegetative cell, bio-tissue, and genome technology. Researchers are predicting new modalities of dialysis, gene modification, and stem cell-generated tissue because the next steps for a healthier life for our uropathy patients.
Advances in Somatic Cell Research for Autologous Tissue
Tissue is going to be wont to grow a brand new kidney to exchange a diseased one, like within the case of polycystic uropathy. Right now, rudimentary stem cells are often replicated, but in time, researchers will develop more complex, architecturally relevant models that are fully functional with a patient’s body, thereby eliminating the necessity for immunosuppressive medication.
the possibility of rejection and other common complications is substantially decreasing due to advances in stem cell-generated shunt technology hold the promise of organically compatible shunts for every dialysis patient. Virtual tissue technology has already identified two different types of cysts in PKD, which is able to help determine more specific drug targets moving forward.
A Baseline of Genomic Data
We are entering a replacement frontier in terms of genetic sequencing and therefore the potential impact it holds on personalized health care. Yet, we don’t know what genes cause what diseases. But within the next 10 years, more people will have their genomes sequenced, creating a knowledge base from which researchers can determine genetic mutations and inheritance patterns. We’ll be able to sequence genes and medical histories in vitro, enabling us to identify potentially harmful mutations and devise more informed treatment protocols. People will sequence their genomes every several years so we will detect environmental influences that would cause disease.
Use of Molecular Data for Precision Medicine
Imagine that after you walk into a clinic, you’ve got a health record that contains a full, detailed history of your health on a cellular level. Molecular blueprints will provide a stimulating amount of detail about our health and well-being with a baseline created in vitro. This may allow doctors to predict disease progression and treatment responsiveness. Through urinary and serum biomarkers with treatments being adjusted thanks to changes in biomarkers and biometrics, Kidney monitoring is done regularly. Physicians will understand how we genetically metabolize medications, reducing the possibilities of ineffective treatments.
Mobile and Bio-artificial Dialysis Technologies
Advancing technology could render current dialysis technologies obsolete. Smaller, mobile technologies will provide temporary metabolic support. Devices will become wearable or take the shape of artificial kidneys that automate metabolic functions. Refining kidney function and treatment, patients will use mobile sensors that collect information on food intake and lifestyle habits. Integrated use of 3D-printed tissue and smart materials are ready to replicate kidney design and performance.
Many of those predictions may sound like phantasy, but continuing research makes their exciting possibilities. Within the next 10 years, the diagnosis and treatment of nephropathy will change tremendously. The promise of a healthier, more autonomous life for our patients makes the long run bright indeed.